Hilgers J - Search Results

1

Evaluation of colorectal cancer-associated mucin CA M43 assay in serum.

van Kamp GJ, von Mensdorff-Pouilly S, Kenemans P, Verstraeten R, Yedema CA, Wobbes T, Bon GG, Kok A, Brown JP, Hilgers J, et al. van Kamp GJ, et al. Among authors: hilgers j. Clin Chem. 1993 Jun;39(6):1029-32. Clin Chem. 1993. PMID: 8504532

2

Use of serum tumor markers in the differential diagnosis between ovarian and colorectal adenocarcinomas.

Yedema CA, Kenemans P, Wobbes T, Thomas CM, Bon GG, Mulder C, Voorhorst FJ, Verstraeten AA, van Kamp GJ, Hilgers J. Yedema CA, et al. Among authors: hilgers j. Tumour Biol. 1992;13(1-2):18-26. doi: 10.1159/000217748. Tumour Biol. 1992. PMID: 1589694

3

Quantitation of polymorphic epithelial mucin: a challenge for biochemists and immunologists.

Hilgers J, von Mensdorff-Pouilly S, Verstraeten AA, Kenemans P. Hilgers J, et al. Scand J Clin Lab Invest Suppl. 1995;221:81-6. doi: 10.3109/00365519509090569. Scand J Clin Lab Invest Suppl. 1995. PMID: 7652493 Review.

4

CA 125 serum levels in the early post-operative period do not reflect tumour reduction obtained by cytoreductive surgery.

Yedema CA, Kenemans P, Thomas CM, Massuger LF, Wobbes T, Verstraeten R, van Kamp GJ, Hilgers J. Yedema CA, et al. Among authors: hilgers j. Eur J Cancer. 1993;29A(7):966-71. doi: 10.1016/s0959-8049(05)80203-5. Eur J Cancer. 1993. PMID: 8499150

5

CA 125 half-life in ovarian cancer: a multivariate survival analysis.

Yedema CA, Kenemans P, Voorhorst F, Bon G, Schijf C, Beex L, Verstraeten A, Hilgers J, Vermorken J. Yedema CA, et al. Among authors: hilgers j. Br J Cancer. 1993 Jun;67(6):1361-7. doi: 10.1038/bjc.1993.252. Br J Cancer. 1993. PMID: 8512822 Free PMC article.

6

Clinical and technical evaluation of ACS BR serum assay of MUC1 gene-derived glycoprotein in breast cancer, and comparison with CA 15-3 assays.

Bon GG, von Mensdorff-Pouilly S, Kenemans P, van Kamp GJ, Verstraeten RA, Hilgers J, Meijer S, Vermorken JB. Bon GG, et al. Among authors: hilgers j. Clin Chem. 1997 Apr;43(4):585-93. Clin Chem. 1997. PMID: 9105258

7

Clinical applications of monoclonal antibodies against ovarian cancer-associated antigens.

Kenemans P, Yedema CA, Hilgers JH, Massuger LF, Verheijen RH, Thomas CM, Poels LG. Kenemans P, et al. Among authors: hilgers jh. Eur J Obstet Gynecol Reprod Biol. 1988 Nov;29(3):207-18. doi: 10.1016/s0028-2243(88)80025-x. Eur J Obstet Gynecol Reprod Biol. 1988. PMID: 3065097 Review.

8

An enzyme-linked immunosorbent assay for the measurement of circulating antibodies to polymorphic epithelial mucin (MUC1).

von Mensdorff-Pouilly S, Gourevitch MM, Kenemans P, Verstraeten AA, van Kamp GJ, Kok A, van Uffelen K, Snijdewint FG, Paul MA, Meijer S, Hilgers J. von Mensdorff-Pouilly S, et al. Among authors: hilgers j. Tumour Biol. 1998;19(3):186-95. doi: 10.1159/000030006. Tumour Biol. 1998. PMID: 9591045

9

Quantification of MUC1 in breast cancer patients. A method comparison study.

Bon GG, van Kamp GJ, Verstraeten RA, von Mensdorff-Pouilly S, Hilgers J, Kenemans P. Bon GG, et al. Among authors: hilgers j. Eur J Obstet Gynecol Reprod Biol. 1999 Mar;83(1):67-75. doi: 10.1016/s0301-2115(98)00302-9. Eur J Obstet Gynecol Reprod Biol. 1999. PMID: 10221613

10

Survival in early breast cancer patients is favorably influenced by a natural humoral immune response to polymorphic epithelial mucin.

von Mensdorff-Pouilly S, Verstraeten AA, Kenemans P, Snijdewint FG, Kok A, Van Kamp GJ, Paul MA, Van Diest PJ, Meijer S, Hilgers J. von Mensdorff-Pouilly S, et al. Among authors: hilgers j. J Clin Oncol. 2000 Feb;18(3):574-83. doi: 10.1200/JCO.2000.18.3.574. J Clin Oncol. 2000. PMID: 10653872

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

234 results

Search Page

Filters